Protagenic Therapeutics (PTIX) — Cash Flow Reinvestment Rate
Protagenic Therapeutics (PTIX) has a Cash Flow Reinvestment Rate of 0.00x as of December 2010, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $1.72 Million. Check Protagenic Therapeutics (PTIX) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Protagenic Therapeutics Cash Flow Reinvestment Rate (1999–2008)
Historical reinvestment intensity for Protagenic Therapeutics across 7 annual periods. Explore PTIX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Protagenic Therapeutics (1999–2008)
Year-by-year capital reinvestment analysis for Protagenic Therapeutics. For live market cap and broader valuation context, see market cap of Protagenic Therapeutics.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2008 | 0.47x | $2.03 Million | $4.36 Million | $2.03 Million | ▲ +463.3% |
| 2006 | 0.08x | $77.00K | $931.00K | $77.00K | ▼ -89.5% |
| 2003 | 0.79x | $1.48 Million | $1.87 Million | $1.48 Million | ▲ +4.1% |
| 2002 | 0.76x | $1.78 Million | $2.35 Million | $1.78 Million | ▼ -69.8% |
| 2001 | 2.52x | $3.79 Million | $1.50 Million | $3.79 Million | ▲ +173.6% |
| 2000 | 0.92x | $3.23 Million | $3.51 Million | $3.23 Million | ▲ +276.3% |
| 1999 | 0.24x | $81.00K | $331.00K | $81.00K | — |